TomoTherapy and Vision RT Partner to Expand Hi-Art(R) System Imaging Options

ASTRO 2008 - TomoTherapy Incorporated Investor Contact: Stephen C. Hathaway Chief Financial Officer 608.824.2800 shathaway@tomotherapy.com or Media Contact: Patty Kitowski Marketing Communications Manager 608.824.2820 pkitowski@tomotherapy.com TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it has partnered with Vision RT to expand imaging options for Hi-Art(R) treatment system users. The companies will jointly introduce AlignRT(R) 3D imaging technology
for the Hi-Art platform at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston, Mass., Sept. 21-25, 2008. TomoTherapy will distribute AlignRT(R) for use with both its TomoHelical(TM) and new TomoDirect(TM) delivery modes.

"We are excited about our strategic alliance with Vision RT, a company that is as focused on best-in-class clinical workflow and high-quality patient treatments as we are," said Fred Robertson, CEO of TomoTherapy. "AlignRT(R) does for Hi-Art system imaging what TomoDirect does for Hi-Art treatment delivery: both provide a new option for our users that can significantly improve patient throughput across a broad range of cancer cases."

source: PR-Inside